|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2007;134:822
© 2007 The American Association for Thoracic Surgery
Letter to the Editor |
Department of Cardiothoracic Surgery, Dokkyo Medical University School of Medicine, Shimotsuga, Japan
To the Editor:
I enjoyed reading the article written by Nomori and colleagues.1
Their strategy for performing a segmentectomy with little risk of local relapse included the following features: (1) Hilar and mediastinal lymph nodes are dissected as much as possible, (2) the lobectomy must be completed when metastasized cancer is found in any of the dissected lymph nodes, and (3) in nested cases with a sentinel node, frozen section histologic examinations can be limited to the sentinel lymph node.
I agree with their strategy regarding local/regional recurrence in the lymphatics. However, the crucial concept of possible local relapse is not addressed, because a relapse of non–small cell lung cancer can occur at the surgical margin, which is independent of the lymphatic system.
When complete excision has been accomplished with compromised patients with clinical stage I non–small cell lung cancer, surgical margin recurrence has been observed in approximately half of the cases with malignant cytologic results, even when the margin showed a malignant negative histology.2,3
Thus, a cytologic malignant positive margin in the residual lung after a segmentectomy has the potential of surgical margin relapse. On the basis of my experience with complete excisions for compromised patients, the segmentectomy should be accompanied by a surgical margin cytologic examination and frozen section histology findings of the dissected hilar and mediastinal lymph node.
I have performed 22 segmentectomies without lymph node metastasis, in which there were 2 cases (9%) with malignant positive cytology results at the surgical margin, for which completion lobectomies were performed. If those residual lobes had been left, surgical margin relapse may have occurred, even though there was no metastasized lymph node. Thus, I recommend performing a surgical margin cytologic examination in patients who undergo a segmentectomy and in cases of excision, because malignant cytology findings have been documented in cases with malignant negative histology findings.4,5
Here are some questions for Dr Nomori and colleagues: What was the status of the margin of the lung that underwent a segmentectomy? Was a margin cytologic examination carried out? Also, what options do you propose if the margin cytology were shown to be malignant positive by a cytologic method?
References
Related Article
This article has been cited by other articles:
![]() |
Y. Funakoshi, N. Sawabata, Y. Takeuchi, H. Kusumoto, T. Kimura, and H. Maeda Clinical implication of pulmonary excision for undiagnosed peripheral lung cancer Interact CardioVasc Thorac Surg, November 1, 2011; 13(5): 485 - 489. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |